| Literature DB >> 32243690 |
Song Chen1,2, Qin Yin3, Huibo Shi1,2, Dunfeng Du1,2, Sheng Chang1,2, Li Ni4, Haifang Qiu3, Zhishui Chen1,2, Jixian Zhang3, Weijie Zhang1,2.
Abstract
In December 2019, an outbreak of COVID-19 occurred in Wuhan, China, and spread to the whole of China and to multiple countries worldwide. Unlike SARS and MERS, where secondary transmission mostly occurred in hospital settings, COVID-19 transmission occurs in large numbers within families. Herein we report three cases of a familial cluster with one family member being a kidney transplant recipient. The initial clinical symptoms of COVID-19 in these three patients were the same, but their progression was different. Based on the severity of clinical symptoms, chest computer tomography findings and SARS-Cov-2 RNA test results, we admitted the husband to the respiratory intensive care unit (RICU) and used a treatment consisting of immunosuppressant reduction/cessation and low dose methylprednisolone-based therapy, and his wife to the respiratory isolation ward. In contrast, the son received in-home isolation and home-based care. All three family members made a full recovery.Entities:
Keywords: COVID-19; kidney; novel coronavirus; pneumonia; transplantation; treatment
Mesh:
Substances:
Year: 2020 PMID: 32243690 DOI: 10.1111/ajt.15903
Source DB: PubMed Journal: Am J Transplant ISSN: 1600-6135 Impact factor: 8.086